|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/546 | (2006.01) |
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 2889034 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14196405.6 |
| Date of filing the European patent application | 2009-08-28 | |
| (97) | Date of publication of the European application | 2015-07-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 92497 P | 2008-08-28 | US |
| (72) |
Biek, Donald, US
|
| (73) |
Pfizer Anti-Infectives AB,
Vetenskapsvägen 10, SE-191 90 Sollentuna,
SE
|
| (54) | Composition comprising ceftaroline and tobramycin |
| Composition comprising ceftaroline and tobramycin |